Recurrent spontaneous intracerebral hemorrhage in a congenitally afibrinogenemic patient: diagnostic pitfalls and therapeutic options

Stroke. 1999 Nov;30(11):2479-82. doi: 10.1161/01.str.30.11.2479.

Abstract

Background: Coagulation disorders can cause intracerebral bleeding that may be difficult to detect since subsequent aberrant clot formation may mask early detection. This is an important pitfall because, when diagnosed early, bleeding in these patients is treatable.

Case description: A patient with congenital afibrinogenemia presented with recurrent hemiparesis. Spontaneous intracerebral hemorrhage was diagnosed, despite an initial negative CT scan. Diagnosis, therapy, and complications of therapy are discussed.

Conclusions: Intracerebral hemorrhage must be strongly suspected in any patient with a coagulation disorder presenting with matching clinical symptoms. Therapy must be installed immediately, before additional investigations, and should be continued even when initial neuroimaging is negative.

Publication types

  • Case Reports

MeSH terms

  • Afibrinogenemia / congenital*
  • Cerebral Hemorrhage / diagnosis
  • Cerebral Hemorrhage / drug therapy
  • Cerebral Hemorrhage / etiology*
  • Factor VIII / administration & dosage
  • Factor VIII / adverse effects
  • Factor VIII / therapeutic use
  • Female
  • Fibrinogen / administration & dosage
  • Fibrinogen / adverse effects
  • Fibrinogen / therapeutic use
  • Fibronectins / administration & dosage
  • Fibronectins / adverse effects
  • Fibronectins / therapeutic use
  • Follow-Up Studies
  • Hemostatics / administration & dosage
  • Hemostatics / adverse effects
  • Hemostatics / therapeutic use
  • Humans
  • Magnetic Resonance Imaging
  • Paresis / etiology
  • Pulmonary Embolism / chemically induced
  • Recurrence
  • Tomography, X-Ray Computed

Substances

  • Fibronectins
  • Hemostatics
  • cryoprecipitate coagulum
  • Factor VIII
  • Fibrinogen